NetraMark Strengthens Board Of Directors

TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”). Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-c ...